SELP and COVID-19: COVID-19 patients in a critical condition expressing ACE2 as well as TMPRSS2, have hyperactive platelets, mean platelet volume above their reference interval, increased activation of αIIbβ3 and P-selectin expression on thrombocytes (10, 30).